• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Motus GI Holdings Shares Are Trading Lower By Around 46%; Here Are 20 Stocks Moving Premarket

    12/19/23 8:09:17 AM ET
    $AHI
    $BLUE
    $BMRA
    $BYTS
    Package Goods/Cosmetics
    Consumer Discretionary
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Get the next $AHI alert in real time by email

    Shares of Motus GI Holdings, Inc. (NASDAQ:MOTS) shares fell sharply in pre-market trading after the company priced its $5 million public offering.

    Motus GI Holdings shares dipped 46.5% to $1.15 in pre-market trading.

    Here are some other stocks moving in pre-market trading.

    Gainers

    • Infobird Co., Ltd (NASDAQ:IFBD) shares rose 128.8% to $3.10 in pre-market trading after the company inked a new business cooperation in software development of information technology system.
    • Jin Medical International Ltd.(NASDAQ:ZJYL) gained 76.7% to $179.96 in pre-market trading after jumping around 264% on Monday.
    • SOBR Safe, Inc. (NASDAQ:SOBR) shares climbed 33.7% to $0.6250 in pre-market trading after declining around 7% on Monday.
    • EG Acquisition Corp. (NYSE:EGGF) shares gained 33.2% to $14.38 in pre-market trading.
    • Nxu, Inc. (NASDAQ:NXU) shares rose 31% to $0.0258 in pre-market trading. Nxu announced that Nasdaq approved company's request for continued listing, subject to Nxu demonstrating compliance with the listing rules on or before April 7, 2024.
    • Panbela Therapeutics, Inc. (NASDAQ:PBLA) shares surged 29.7% to $1.31 in pre-market trading. Panbela Therapeutics shares jumped 120% on Monday after US WorldMeds received FDA approval of eflornithine.
    • Yoshiharu Global Co. (NASDAQ:YOSH) rose 23.1% to $6.30 in pre-market trading.
    • Hanryu Holdings, Inc. (NASDAQ:HRYU) shares gained 18.7% to $1.27 in pre-market trading after falling around 12% on Monday.
    • Sidus Space, Inc. (NASDAQ:SIDU) gained 16.5% to $0.0466 in pre-market trading. Sidus Space shares fell over 20% on Monday after the company announced a 1-for-100 reverse stock split.
    • The NFT Gaming Company, Inc. (NASDAQ:NFTG) shares rose 15.3% to $0.37 in pre-market trading. NFT Gaming Company recently announced newest game launch, Battle Fleet AI.

    Losers

    • ETAO International Co., Ltd. (NASDAQ:ETAO) shares fell 29.4% to $0.3245 in pre-market trading. ETAO International received a staff determination letter, on Dec. 13, 2023, from the Listing Qualifications Department of The Nasdaq Stock Market LLC.
    • bluebird bio, Inc. (NASDAQ:BLUE) shares fell 15.4% to $2.58 in pre-market trading after the company announced a proposed public offering of $150 million of common stock.
    • BYTE Acquisition Corp. (NASDAQ:BYTS) shares fell 15.1% to $8.30 in pre-market trading. BYTE Acquisition reported adjournment of shareholder meeting to approve business combination with Airship AI to 4:00 p.m. ET, Dec. 19, 2023.
    • ZyVersa Therapeutics, Inc. (NASDAQ:ZVSA) fell 13.8% to $0.9220 in pre-market trading after surging 38% on Monday.
    • iCoreConnect Inc. (NASDAQ:ICCT) fell 12.5% to $2.02 in pre-market after jumping over 35% on Monday.
    • Advanced Health Intelligence Ltd. (NASDAQ:AHI) fell 11.5% to $1.70 in pre-market trading. Advanced Health Intelligence said it Will launch medically approved mobile phone-based Atrial Fibrillation assessment in the second quarter of 2024.
    • Ebix, Inc. (NASDAQ:EBIX) shares fell 11.3% to $1.42 in pre-market trading. Ebix shares fell around 67% on Monday after the company and certain US affiliates filed for protection under Chapter 11 and reached a stalking horse agreement to sell its North American Life and Annuity assets to Zinnia.
    • Alaunos Therapeutics, Inc (NASDAQ:TCRT) fell 10.1% to $0.0516 in pre-market trading after jumping 26% on Monday.
    • Biomerica, Inc. (NASDAQ:BMRA) shares fell 9.7% to $1.49 in pre-market trading. Biomerica shares gained around 67% on Monday after the company received FDA 510(k) clearance for its Hp Detect ELISA test product.

     

    Now Read This: Fear & Greed Index Remains In ‘Extreme Greed’ Zone; S&P 500 Settles Higher

    Get the next $AHI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AHI
    $BLUE
    $BMRA
    $BYTS

    CompanyDatePrice TargetRatingAnalyst
    bluebird bio Inc.
    $BLUE
    2/24/2025Underweight → Neutral
    Analyst
    bluebird bio Inc.
    $BLUE
    2/24/2025$29.00Overweight
    Analyst
    bluebird bio Inc.
    $BLUE
    11/18/2024Neutral → Underweight
    Analyst
    bluebird bio Inc.
    $BLUE
    11/15/2024Neutral → Underweight
    JP Morgan
    bluebird bio Inc.
    $BLUE
    11/15/2024$3.00 → $0.50Buy → Neutral
    BofA Securities
    bluebird bio Inc.
    $BLUE
    8/15/2024Overweight → Neutral
    JP Morgan
    Advanced Health Intelligence Ltd.
    $AHI
    5/30/2024Buy → Hold
    Maxim Group
    bluebird bio Inc.
    $BLUE
    12/11/2023Hold → Reduce
    HSBC Securities
    More analyst ratings

    $AHI
    $BLUE
    $BMRA
    $BYTS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Bluebirdbio upgraded by Analyst

    Analyst upgraded Bluebirdbio from Underweight to Neutral

    2/24/25 7:05:14 AM ET
    $BLUE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Analyst initiated coverage on Bluebirdbio with a new price target

    Analyst initiated coverage of Bluebirdbio with a rating of Overweight and set a new price target of $29.00

    2/24/25 7:04:33 AM ET
    $BLUE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Bluebirdbio downgraded by Analyst

    Analyst downgraded Bluebirdbio from Neutral to Underweight

    11/18/24 4:13:05 AM ET
    $BLUE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AHI
    $BLUE
    $BMRA
    $BYTS
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Shuman Jeffrey S bought $24,689 worth of shares (15,000 units at $1.65) (SEC Form 4)

    4 - Sidus Space Inc. (0001879726) (Issuer)

    6/13/25 4:15:18 PM ET
    $SIDU
    Telecommunications Equipment
    Telecommunications

    Large owner Schonfeld Strategic Advisors Llc sold $79,589 worth of shares (41,400 units at $1.92) and bought $372,143 worth of shares (146,800 units at $2.54) (SEC Form 4)

    4 - iCoreConnect Inc. (0001906133) (Issuer)

    4/28/25 6:12:27 PM ET
    $ICCT
    Computer Software: Prepackaged Software
    Technology

    President Pratt Annie bought $15,246 worth of shares (61,733 units at $0.25), increasing direct ownership by 4% to 508,169 units (SEC Form 4)

    4 - Nxu, Inc. (0001722969) (Issuer)

    3/18/25 4:13:25 PM ET
    $NXU
    Construction/Ag Equipment/Trucks
    Consumer Discretionary

    $AHI
    $BLUE
    $BMRA
    $BYTS
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    December 8, 2023 - FDA Approves First Gene Therapies to Treat Patients with Sickle Cell Disease

    For Immediate Release: December 08, 2023 Today, the U.S. Food and Drug Administration approved two milestone treatments, Casgevy and Lyfgenia, representing the first cell-based gene therapies for the treatment of sickle cell disease (SCD) in patients 12 years and older. Additionally, one of these therapies, Casgevy, is the first FDA-approved treatment to utilize a type of novel genome editing technology, signali

    12/8/23 11:12:21 AM ET
    $BLUE
    $VRTX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    August 17, 2022 - FDA Approves First Cell-Based Gene Therapy to Treat Adult and Pediatric Patients with Beta-thalassemia Who Require Regular Blood Transfusions

    For Immediate Release: August 17, 2022 Today, the U.S. Food and Drug Administration approved Zynteglo (betibeglogene autotemcel), the first cell-based gene therapy for the treatment of adult and pediatric patients with beta-thalassemia who require regular red blood cell transfusions.  “Today’s approval is an important advance in the treatment of beta-thalassemia, particularly in individuals who require ongoing

    8/17/22 2:12:27 PM ET
    $BLUE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AHI
    $BLUE
    $BMRA
    $BYTS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Sidus Space Advances its Fortis Next-Generation Command and Data Handling (C&DH) System

    Microchip collaboration enables accelerated, modular, and mission‑scalable OpenVPX architectures for space and defense applications CAPE CANAVERAL, Fla., April 23, 2026 /PRNewswire/ -- Sidus Space, Inc. (NASDAQ:SIDU) ("Sidus" or the "Company"), an innovative space and defense technology company, today announced continued advancements to its Fortis Command and Data Handling (C&DH) platform, a modular 3U OpenVPX system designed to support rapid development, configuration flexibility, and long-term scalability across next-generation space and defense missions. Supported by a strate

    4/23/26 8:31:00 AM ET
    $SIDU
    Telecommunications Equipment
    Telecommunications

    Sidus Space Announces Closing of Offering

    CAPE CANAVERAL, Fla., April 21, 2026 /PRNewswire/ -- Sidus Space, Inc. (NASDAQ:SIDU) ("Sidus" or the "Company"), an innovative space and defense technology company, today announced the closing of its previously announced best-efforts offering of 13,453,700 shares of its Class A common stock (or pre-funded warrants ("Pre-funded Warrants") in lieu thereof). Each share of Class A common stock (or Pre-funded Warrant) was sold at an offering price of $4.35 per share (inclusive of the Pre-funded Warrant exercise price) for gross proceeds of approximately $58.5 million, before deducting the placement agent's fees and offering expenses. All of the shares of Class A common stock and Pre-funded Warran

    4/21/26 4:00:00 PM ET
    $SIDU
    Telecommunications Equipment
    Telecommunications

    Sidus Space Announces Pricing of $58.5 Million Registered Direct Offering of Class A Common Stock

    CAPE CANAVERAL, Fla., April 19, 2026 /PRNewswire/ -- Sidus Space, Inc. (NASDAQ:SIDU) ("Sidus" or the "Company"), an innovative space and defense technology company, today announced the pricing of a best-efforts registered direct offering of 13,453,700 shares of its Class A common stock (or pre-funded warrants ("Pre-funded Warrants") in lieu thereof) at an offering price of $4.35 per share (inclusive of the Pre-funded Warrant exercise price) for gross proceeds of approximately $58.5 million, before deducting the placement agent's fees and offering expenses. All of the shares of Class A common stock and Pre-funded Warrants are being offered by the Company.

    4/19/26 5:01:00 PM ET
    $SIDU
    Telecommunications Equipment
    Telecommunications

    $AHI
    $BLUE
    $BMRA
    $BYTS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Guo Yanru

    3 - Jin Medical International Ltd. (0001837821) (Issuer)

    4/24/26 10:44:35 AM ET
    $ZJYL
    Industrial Specialties
    Health Care

    New insider Wang Erqi claimed ownership of 4,306,307 units of Class A Ordinary Shares and claimed ownership of 1,000,000 units of Class B Ordinary Shares (SEC Form 3)

    3 - Jin Medical International Ltd. (0001837821) (Issuer)

    4/24/26 10:43:55 AM ET
    $ZJYL
    Industrial Specialties
    Health Care

    SEC Form 3 filed by new insider Wang Ziqiang

    3 - Jin Medical International Ltd. (0001837821) (Issuer)

    4/24/26 10:42:49 AM ET
    $ZJYL
    Industrial Specialties
    Health Care

    $AHI
    $BLUE
    $BMRA
    $BYTS
    SEC Filings

    View All

    SEC Form 424B5 filed by Sidus Space Inc.

    424B5 - Sidus Space Inc. (0001879726) (Filer)

    4/20/26 5:20:12 PM ET
    $SIDU
    Telecommunications Equipment
    Telecommunications

    Sidus Space Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits

    8-K - Sidus Space Inc. (0001879726) (Filer)

    4/20/26 5:13:07 PM ET
    $SIDU
    Telecommunications Equipment
    Telecommunications

    SOBR Safe Inc. filed SEC Form 8-K: Other Events

    8-K - SOBR Safe, Inc. (0001425627) (Filer)

    4/17/26 4:15:45 PM ET
    $SOBR
    Newspapers/Magazines
    Consumer Discretionary

    $AHI
    $BLUE
    $BMRA
    $BYTS
    Financials

    Live finance-specific insights

    View All

    The Only Mach 2+ Commercial Fleet in the World Is Now Testing Reusable Hypersonic Space Systems -- and the Pentagon Is Writing the Checks

    Issued on behalf of Starfighters Space, Inc.CAPE CANAVERAL, Fla., April 2, 2026 /CNW/ -- USA News Group News Commentary — The next arms race isn't being fought on the ground. It's being fought at 45,000 feet and Mach 2, in the stratosphere where hypersonic weapons are validated, reusable space systems are tested, and the gap between the United States and its adversaries is either closed or conceded. The Pentagon knows it. Congress knows it. And the capital flowing into the commercial aerospace sector right now reflects exactly that urgency. The U.S. Space Force is operating on a

    4/2/26 2:02:00 PM ET
    $ASTS
    $FJET
    $LUNR
    Telecommunications Equipment
    Consumer Discretionary
    Air Freight/Delivery Services
    Industrial Machinery/Components

    SIDUS SPACE REPORTS FULL-YEAR 2025 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATES

    CAPE CANAVERAL, Fla., April 1, 2026 /PRNewswire/ -- Sidus Space, Inc. (NASDAQ:SIDU) (the "Company" or "Sidus"), an innovative space and defense technology company, announced its financial results for the fourth quarter and full-year ended December 31, 2025, and provided a business update. "2025 was a pivotal year for Sidus as we continued executing our long‑term strategy to build vertically integrated space and defense technology platforms," said Carol Craig, Founder and CEO of Sidus Space. "We expanded our on‑orbit capabilities with the successful launch and commissioning of Li

    4/1/26 6:01:00 AM ET
    $MTEK
    $SIDU
    Telecommunications Equipment
    Telecommunications

    ZyVersa Therapeutics Reports Full Year 2025 Financial Results and Provides Business Update

    ZyVersa is advancing a highly differentiated pipeline focusing on inflammatory and renal diseases with a total accessible market >$100 billion.Inflammasome ASC Inhibitor IC 100 is a next generation drug designed for unparalleled control of disease-causing inflammation by (1) inhibiting multiple inflammasomes activated in numerous diseases, not just NLRP3, and (2) attenuating spread and perpetuation of inflammation by uniquely inhibiting ASC specks. Lead indication: Cardiometabolic conditions associated with obesityValue driving milestones: File IND Q4-2026; Phase 1 SAD read-out Q1-2027 Cholesterol Efflux Mediator VAR 200 is expected to be a disease-modifying renal drug by targeting unaddress

    3/31/26 5:05:00 PM ET
    $ZVSA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AHI
    $BLUE
    $BMRA
    $BYTS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by iCoreConnect Inc.

    SC 13G/A - iCoreConnect Inc. (0001906133) (Subject)

    12/12/24 9:44:00 PM ET
    $ICCT
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13G/A filed by iCoreConnect Inc.

    SC 13G/A - iCoreConnect Inc. (0001906133) (Subject)

    12/5/24 4:08:58 PM ET
    $ICCT
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13G/A filed by Sidus Space Inc.

    SC 13G/A - Sidus Space Inc. (0001879726) (Subject)

    11/14/24 7:31:47 PM ET
    $SIDU
    Telecommunications Equipment
    Telecommunications

    $AHI
    $BLUE
    $BMRA
    $BYTS
    Leadership Updates

    Live Leadership Updates

    View All

    Sidus Space Appoints Aerospace Executive Kelle Wendling to Board of Directors

    Veteran Space and Defense Leader Brings Three Decades of Government Contracting, ISR, and Space Systems Expertise to Sidus Board CAPE CANAVERAL, Fla., Jan. 5, 2026 /PRNewswire/ -- Sidus Space, Inc. (NASDAQ:SIDU) ("Sidus" or the "Company"), an innovative space and defense technology company, today announced the appointment of accomplished aerospace and defense executive Kelle Wendling to its Board of Directors. Ms. Wendling brings more than three decades of executive leadership and government contracting experience across space systems, Intelligence, Surveillance and Reconnaissance (ISR), and Federal Aviation Administration (FAA) markets.

    1/5/26 8:30:00 AM ET
    $SIDU
    Telecommunications Equipment
    Telecommunications

    Gary Huff, Former CEO of LabCorp Diagnostics, Appointed to Biomerica Board of Directors

    Brings decades of leadership in laboratory testing, clinical diagnostics, payor strategy, and sales growth Extensive track record in commercializing advanced laboratory testing and insurer strategies IRVINE, Calif., Oct. 08, 2025 (GLOBE NEWSWIRE) -- Biomerica Inc. (NASDAQ:BMRA), a global provider of advanced diagnostic solutions, today announced the appointment of Gary Huff to its Board of Directors as an independent board member. Mr. Huff brings decades of leadership experience in the diagnostics and healthcare services industry, including serving as Chief Executive Officer of LabCorp Diagnostics, one of the world's largest clinical laboratories. Mr. Huff is a hands-on, inspirational,

    10/8/25 8:19:00 AM ET
    $BMRA
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    Sidus Space Appoints Lawrence Hollister as Chief Business Officer to Drive Strategic Growth and Market Expansion

    Sidus Space (NASDAQ:SIDU), (the "Company" or "Sidus"), an innovative space and defense technology company, today announced the appointment of Lawrence Hollister as its new Chief Business Officer, effective September 15, 2025, to accelerate growth across commercial and government markets. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250915521625/en/Sidus Space Appoints Lawrence Hollister as Chief Business Officer Mr. Hollister joins Sidus with a distinguished track record of driving revenue growth, scaling operations, and executing strategic initiatives across defense, aerospace, intelligence, cyber, and federal civil sectors.

    9/15/25 8:30:00 AM ET
    $SIDU
    Telecommunications Equipment
    Telecommunications